Med Biogene (MBI.H) Stock Statistics & Valuation Metrics

Med Biogene has a market cap or net worth of C$431.45K. The enterprise value is C$0.34.

Med Biogene has 17,257,837 shares outstanding. The number of shares has decreased by -2.65% in one year.

Med Biogene’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Med Biogene is ―. Med Biogene’s PEG ratio is ―.

In the last 12 months, Med Biogene had revenue of ― and earned -58.11K in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Med Biogene pays an annual dividend of ―, resulting in a dividend yield of ―

Med Biogene upcoming earnings date is Nov 20, 2026, TBA (Confirmed).

Med Biogene as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Med Biogene has paid ― in taxes.

Med Biogene EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Med Biogene has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Med Biogene is ―, which is 11.43% higher than the current price. The consensus rating is ―